VAXX — Vaxxinity Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.03m
- -$15.20m
Annual balance sheet for Vaxxinity, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.476 | 31.1 | 145 | 86.8 | 30.4 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.303 | 0.387 | 0.393 | 0.414 | 0.414 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1.44 | 35.7 | 154 | 93.9 | 33.2 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.16 | 12.2 | 12.4 | 12.5 | 11.1 |
| Other Long Term Assets | |||||
| Total Assets | 1.59 | 50.1 | 167 | 106 | 44.3 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 19.9 | 37.2 | 27.5 | 30.9 | 17.6 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 23.3 | 75 | 38.1 | 44.2 | 30.9 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | -21.7 | -24.9 | 129 | 62.2 | 13.4 |
| Total Liabilities & Shareholders' Equity | 1.59 | 50.1 | 167 | 106 | 44.3 |
| Total Common Shares Outstanding |